We wrote about Brain Scientific’s NeuroCap earlier this year. NeuroCap is a disposable, pre-gelled EEG headset with 19 active channels and 22 electrodes. The FDA cleared the NeuroCap as a single-use EEG headset for use in the U.S. The NeuroCap setup time averages less than five minutes when the headset is used with Brain Scientific’s NeuroEEG signal amplifier. A significant number of COVID-19 patients in intensive care may have neurological diseases. Fast set up time can be a big deal under any circumstancs, but especially during the pandemic because it cuts healthcare worker’s close exposure time with patients.
Earlier this month, Brain Scientific announced the NeuroCap will now be available for pediatric patients in the U.S. The child-sized EEG headset will reduce the time normally required to measure and mark a pediatric patient’s head, as well as for post-test sanitation protocols. According to Brain Scientific, the NeuroCap is an easy-to-use solution for children aged from 2 to 18 years old and is appropriate to use in emergency rooms, intensive care units, and clinics.
Young patients can require EEG tests for seizures, sleep problems, brain infection, neurological disorders, and pediatric epilepsy. Physicians also often order EEGs for children with symptoms of ADHD.
The pediatric NeuroCap is a wonderful example of a wearable technology that over-delivers due to its timeliness. No one could have predicted COVID-19 and certainly most of the products such as NeuroCap weren’t originally conceived as a protection against pandemic infections. It has been interesting to realize that many wearable technologies — especially those that support telemedicine and remote patient monitoring — appeared in a just-in-time fashion.
